We have examined whether a molecule that is capable of inducing immune protection, the major secretory protein (MSP) of Legionella pneumophila, is required for virulence in a guinea pig model of Legionnaires' disease. To do so, we have compared the virulence in guinea pigs of an isogenic pair of L. pneumophila, Philadelphia 1 strain, one of which produces MSP (MSP+) and one of which does not (MSP-). Both the MSP-strain and the MSP+ strain of L. pneumophila are highly virulent for guinea pigs, inducing similar signs and progression of illness. Both strains are lethal and have comparable LD50s and LD100s. Both strains multiply in the lungs of guinea pigs at a similar rate, and both strains produce indistinguishable pathological lesions in the lungs. Both strains maintain a stable phenotype with guinea pig passage, i.e., the MSP-strain does not regain the capacity to secrete MSP and the MSP+ strain retains its capacity to secrete MSP after lung passage. Although vaccination with MSP induces strong protective immunity in the guinea pig against lethal aerosol challenge with L. pneumophila, this protective immunogen is not required in its intact proteolytically active form for the expression of virulence by the intracellular pathogen L. pneumophila. This demonstrates that a protective immune response need not necessarily be directed against a virulence determinant and suggests that […] 
Introduction
Legionella pneumophila is a facultative intracellular bacterial pathogen that causes 80-85% of the cases of Legionnaires' disease, a serious and often fatal form of pneumonia (1, 2) . Several potential virulence factors have been identified in L.
pneumophila including an acid phosphatase (3, 4) , phospholipase (5) , the mip gene product (6, 7) , and proteases (8) (9) (10) (11) (12) . Except for the mip gene product, which potentiates infection with L. pneumophila, none of these factors has been shown to be necessary for the full expression of virulence by L. pneumophila.
A previous study from one of our laboratories demonstrated that the L. pneumophila Philadelphia 1 major secretory protein (MSP),' a metalloprotease of apparent mol wt 39,000, induces strong cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. This study showed that (a) guinea pigs sublethally infected with aerosolized L. pneumophila develop a strong cell-mediated immune response to MSP, as measured by splenic lymphocyte proliferation and cutaneous delayed-type hypersensitivity; (b) guinea pigs vaccinated subcutaneously with purified MSP develop strong humoral and cell-mediated immune responses to MSP; and (c) guinea pigs vaccinated with MSP develop a very high level of protective immunity against lethal aerosol challenge with L. pneumophila (13) .
Other investigators have suggested a pathogenic role for a major protease of L. pneumophila (10-1 1) . Conlan et al. inoculated guinea pigs intranasally or intratracheally with an L. pneumophila protease of nearly the same apparent molecular weight as MSP and observed inflammatory pathologic lesions which appeared similar to those produced by aerosolization of L. pneumophila into the lungs of guinea pigs (10, 1 1). Keen and Hoffman (14) and Quinn and Tompkins (15) have demonstrated that MSP has cytotoxic activity.
Traditionally, vaccinogens have been viewed as inducing protective immunity to infectious agents by stimulating an immune response that is capable of neutralizing virulence determinants such as toxins, adhesins, resistance factors, etc.
Thus, if MSP were a virulence determinant, one way that vaccination with MSP might induce protective immunity against L. pneumophila would be by neutralizing MSP activity. Alternatively, however, in the case of an intracellular pathogen, vaccinogens might potentially induce protective immunity by expanding a population of effector cells of the immune system that are capable of recognizing and exerting an antimicrobial effect against infected host cells. Thus This study demonstrates that, although MSP is a potent immunogen with the capacity to induce protective immunity, the intact proteolytically active molecule is not required for virulence in the guinea pig model of Legionnaires' disease. Therefore, this study demonstrates that vaccinogens can induce protective immunity in ways other than by neutralizing virulence determinants, such as by enhancing the capacity of the immune system to detect and respond effectively to an intracellular pathogen.
Methods
Animals. Male Hartley strain guinea pigs weighing 450-500 g, purchased from Charles River Breeding Laboratories (North Wilmington, MA) were housed, no more than four to a stainless steel cage, and allowed free access to ascorbic acid-fortified chow and water. Guinea pigs were observed in the vivarium for signs of illness for 1 wk before challenge with L. pneumophila to ensure that they were healthy; no illnesses or deaths occurred in guinea pigs before challenge. After challenge, guinea pigs were held in filter-top cages for 1 wk. During this time, they were observed for signs of illness and survival was quantitated.
Media. Each liter of yeast extract broth (YEB) was prepared with lO g of ACES (Sigma Chemical Co., St. Louis, MO), 10 g yeast extract (Difco Laboratories, Detroit, MI), 0.4 g L-cysteine HCL (Fisher Scientific Co., Fair Lawn, NJ), and 0.25 g ferric pyrophosphate (Sigma Chemical Co.), adjusted to a pH of 6.9 with 10 N KOH, and filter sterilized. Egg yolk buffer (EYB) with or without 1% BSA (Miles Laboratories, Inc., Naperville, IL) was prepared as previously described (1). Agar. Modified charcoal yeast extract agar (CYEA) was prepared as described (1) . Modified CYEA without cysteine and tryptic soy agar with 5% sheep blood were used to assay for contamination of non-Legionella species as described (1).
Bacteria. An isogenic pair ofLegionella pneumophila, Philadelphia I strain, one of which is MSP+ (LS2029) and one of which is MSP-(LS2102) was constructed (I5a). The MSP-mutant was constructed by insertion of transposon Tn9 in the structural gene for MSP, mspA. The mspA gene was identified in a library ofL. pneumophila, Philadelphia I strain, genomic DNA after transfer to an Escherichia coli host strain. Transposon Tn9 insertions in the mspA gene were constructed in E. coli. A total of six independent Tn9 insertions throughout the MSP coding sequence were transferred to the genome of the L. pneumophila, Philadelphia 1 strain derivative, LS2029. All six mutant strains exhibited the same low level of caseinolytic activity (0.2%) compared to LS2029. In addition, all six strains retained their virulence for human macrophages differentiated from the HL-60 cell line. One mutant strain, LS2102, was studied in detail and was found to grow as well as the parental LS2029 strain within HL-60-derived macrophages. LS2102 was found to produce a small amount of a polypeptide of lower apparent molecular weight than MSP, which appeared to cross-react with polyclonal rabbit anti-MSP antiserum; the amount of this polypeptide produced by the mutant was -1% of the amount of MSP produced by the wild type. This polypeptide may represent an amino terminal fragment of MSP (1 5a).
The MSP+ and MSP-bacteria selected for study were grown on CYEA; washed with EYB; flash frozen in aliquots of 10" CFU/ml; stored at -70'C; and tested for the presence ofcontaminating bacteria as previously described (1) .
Infection ofguinea pigs. Guinea pigs were infected by exposure to aerosols of bacteria in the same lucite aerosol chamber described in detail in a previous study (16). Briefly, the chamber had sealable portals for introducing or removing guinea pigs, an aerosol inlet at the chamber ceiling, and an aerosol nebulizer system (Dart Industries, Ocala, FL). A vacuum pump (Gast Mfg. Co., Benton Harbor, MI) delivered positive pressure to the nebulizer and negative pressure to the chamber. Guinea pigs were infected by exposure for 30 min to an aerosol generated from a 10-ml suspension containing 1.5 X I0O to 1.0 X 109 CFU/ml of the MSP-strain ofL. pneumophila, or 2.5 X I07 to 1.0 X 109 CFUJ/ml of the MSP+ strain of L. pneumophila. After the pump to the nebulizer was shut off, the guinea pigs were held inside the chamber for an additional 10 min before being removed and placed in filter-top cages, three to a cage. Guinea pigs shared cages only with animals exposed to the same type and dose of aerosol. After the challenge, the number of survivors in each group of animals was quantitated over a 7-d period. Each experiment was performed in duplicate.
Quantitation ofthe MSP-and MSP+ strain ofL. pneumophila in pulmonary tissue. In two independent experiments, guinea pigs were infected with an aerosol generated from a I0-ml suspension of 2.5 X 108 CFU/ml ofeither the MSP-or MSP+ strain ofL. pneumophila. In a third experiment, guinea pigs were infected with an aerosol generated from a I0-ml suspension of 7.5 X 107 CFU/ml for the MSP-and 1.5 X I0O CFU/ml for the MSP+ strain ofL. pneumophila. At various time points 3 to 72 h after challenge, one guinea pig infected with an MSP-and one infected with an MSP+ strain ofL. pneumophila were killed by hypercarbia. The animal was soaked first in 7X cleaning solution (Linbro Chemical Co., New Haven, CT) and then in 70% ethanol to decontaminate the skin, and the lungs were removed by sterile technique. The left lung was set aside for pathological examination (see below). The right lung was placed in 10 ml of sterile EYB, ground thoroughly with a mortar and pestle, and serially diluted in EYB with 1% BSA. CFU was determined by plating serial logarithmic dilutions of the lung suspension in EYB with 1% BSA in triplicate on CYEA. On serial plates, CFU decreased by -10-fold from plate to plate, i.e., by the dilution factor, as expected. Lung suspensions were not subjected to hypotonic lysis before plating because control studies demonstrated that few intact lung cells remain in the suspensions after grinding with the mortar and pestle and that hypotonic lysis does not alter bacterial counts. The lung suspensions were also tested for the presence of contaminating bacteria as described (1), and none were contaminated.
Pathology. The left lung from a guinea pig infected with either the MSP-or the MSP+ strain ofL. pneumophila was excised 48 and 72 h after infection as described in the preceding paragraph. Tissue samples from three areas ofeach lung were fixed in 10% formalin, embedded in paraffin, sliced with a microtome, stained with hematoxylin and eosin, and examined by light microscopy. The experiment was performed three times.
Secretion ofMSP by the MSP-and MSP+ strains ofL. pneumophila before and after passage through guinea pig lungs. Extracellular proteins were obtained from the MSP-and MSP+ strain of L. pneumophila before and after passage in guinea pigs. Passaged strains of L. pneumophila were cultured from guinea pig lungs 72 h after infection. In two independent experiments (A and B), groups of guinea pigs were challenged with an aerosol generated from a suspension containing various concentrations of the MSP-or MSP+ strain of L. pneumophila, as indicated, and survival was quantitated.
The extracellular proteins were obtained as previously described with minor modifications (13) . Briefly, the bacteria were grown on CYEA plates; suspended at an initial OD of 0.05 at 540 nm in 10 ml of prewarmed YEB; and grown in 55 ml screw-cap conical polypropylene tubes for 20 h at 370C on a platform rotating at 120 rpm. When a final OD of 1.0 was reached, the culture was tested for the presence of contaminants by inoculating CYEA without L-cysteine and tryptic soy agar with 5% sheep blood. The bacteria were pelleted by centrifugation, and the supernate was decanted and filtered to remove residual bacteria. EDTA was added to each filtrate to a concentration of 0.01 M. The extracellular proteins thus obtained were examined by SDS-PAGE (17) and Western immunoblot analysis (18) using the alkaline phosphatase technique (19) with the following modifications. For both blocking and the dilution of antibody reagents, a solution containing 0.01 M Tris, 0.15 M NaCl, 0.5% Tween-20, and 0.02% sodium azide was used. Affinity purified monospecific anti-MSP rabbit antibody (1.5 ng/ml) was used as a probe for MSP; a 1:1,000 dilution ofalkaline phosphatase-conjugated goat anti-rabbit IgG (heavy and light chain specific) (Cappel Laboratories, West Chester, PA) was used as the enzyme conjugate; and an enzyme substrate solution prepared by adding 500 ,l of 0.1% nitroblue tetrazolium (Sigma Chemical Co.) in distilled water and 100 Ml of0.5% 5-bromo4-chloro-indolyl phosphate (Sigma Chemical Co.) in anhydrous dimethyl formamide (Pierce Chemical Co., Rockford, IL) to 9.5 ml of 0.05 M Tris, pH 10, containing 0.03 M MgCl2, was used to develop the reaction. The reaction was halted by rinsing the immunoblot with distilled water.
Proteolytic activity ofextracellular proteins produced by the MSPand MSP+ strains before and after passage through guinea pig lungs. 
Results
The MSP-strain ofL. pneumophila is virulentfor guinea pigs at challenge doses comparable to those ofthe MSP+ strain. In two independent experiments, we infected groups of guinea pigs with various aerosolized doses of the MSP-and MSP+ strain of L. pneumophila and quantitated survival. Both strains were lethal for guinea pigs (Table I) . For both strains, 100% of guinea pigs were killed by aerosols generated from a suspension containing 5 X 10' or more CFU of L. pneumophila/ml. The 50% lethal dose (LD50) for the MSP-strain was an aerosol generated from a suspension containing 4.8 X 10' CFU/ml (log LD50±SE = 7.68±2.19). Similarly, the LD50 for the MSP+ strain was an aerosol generated from a suspension containing 4.9 X 107 CFU/ml (log LDso±SE = 7.69±2.20). The difference in LD50s was not significant (P = 0.73). The SE for the difference (0.01) between the LD50's for the two strains was 0.10 (log CFU/ml). Given this SE of the difference, at the 5% alpha level, the power for detecting a difference of 0.5 log CFU/ml or larger between the LD50's of the two strains was over 90%. The shape of the guinea pig survival curve (proportion surviving by log dose) for the two strains was also similar; sigma±SE for the MSP-strain was 0.29±0.08 (log CFU/ml), while sigma±SE for the MSP+ strain was 0.27±0.07, a difference which was not significant (P = 0.72). Guinea pigs infected with the MSP-and MSP+ strain of L. pneumophila exhibited similar onset and signs of illness including respiratory distress, decreased activity, and decreased feeding.
The MSP-and MSP+ strain ofL. pneumophila multiply at the same rate in guinea pig lungs. (Fig. 1, A and B) , where the guinea pigs were infected with approximately the same number of MSP-and MSP+ L. pneumophila, the two strains of bacteria multiplied at essentially the same rate, although there were inconsistent differences at one time point or another. In the third experiment (Fig. 1 C) , where guinea pigs infected with the MSP-strain received -1 log fewer bacteria than guinea pigs infected with the MSP+ strain, the bacteria also multiplied at comparable rates so that the growth curves of the two strains parallelled each other throughout the course of the experiment.
MSP-and MSP+ strains ofL. pneumophila cause similar pathological lesions in the lungs of infected guinea pigs. To compare the pathological lesions induced by the MSP-and MSP+ strain of L. pneumophila in the lungs ofguinea pigs, we infected guinea pigs with the bacteria, excised the left lung 48 and 72 h later, processed the tissues for pathological examination, and examined them by light microscopy. In lung specimens from guinea pigs infected with either strain of L. pneumophila, we observed infiltrates of mononuclear and polymorphonuclear cells, pink exudates in some alveoli, evidence ofhemorrhage, and consolidation ofalveolar airspaces (Fig. 2) .
Inflammatory cell infiltration and consolidation increased with time. Some areas of nodular mononuclear cell infiltration were seen. There was no difference in the pathology induced by the MSP-and MSP+ strain of L. pneumophila.
The MSP-and MSP+ strain do not change phenotype with lung passage. To examine the possibility that the MSPstrain of L. pneumophila mutates and regains the capacity to produce MSP during the course of infection, we examined the extracellular proteins of the MSP-and MSP+ strains before and after infection of guinea pigs. The extracellular proteins were examined for the presence of MSP by SDS-PAGE and Western immunoblot analysis. The MSP-strain of L. pneumophila did not produce MSP before or 72 h after passage in guinea pig lung. In contrast, the MSP+ strain of L. pneumophila produced MSP both before and 72 h after passage in guinea pig lung (Fig. 3) . Thus, with regard to MSP production, the MSP-and MSP+ strain do not change phenotype after lung passage.
The proteolytic activity of the MSP-and MSP+ strain does not change with lung passage. To determine if the proteolytic activity of the extracellular proteins of the MSP-and MSP+ strain of L. pneumophila remains stable with guinea pig passage, we assayed proteolytic activity of the strains before and after guinea pig passage (Table II) . The extracellular proteins of the MSP+ strain exhibited abundant proteolytic activity both before and after passage through guinea pig lung; there was no significant difference in proteolytic activity before and after passage (P > 0.05 by the t test, two-tailed). In contrast, the extracellular proteins of the MSP-strain exhibited little proteolytic activity either before or after passage through guinea pig lung. The OD readings for the MSP-strain both before and after passage were < 0.05, below the range for accurate spectrophotometric readings. Thus, also with regard to proteolytic activity, the MSP-and MSP+ strain maintain their phenotype with lung passage.
Discussion
This study demonstrates that MSP production by L. pneumophila is not required for the full expression of virulence by this intracellular bacterial pathogen in the guinea pig model of Legionnaires' disease. Both the MSPhighly virulent for guinea pigs. The two signs and progression of illness. The tw comparable doses and had similar LI C D virulence potential of the resultant mutant L. pneumophila in the guinea pig model. The phenotype of the MSP-and MSP+ strain remains stable through passage in guinea pig lung. The MSP-strain did not regain the capacity to secrete MSP after lung passage and the MSP+ strain retained its capacity to secrete MSP after lung passage. Parallelling this, the MSP-strain remained deficient in proteolytic activity through passage in guinea pig lung, while the MSP+ strain retained its high level of proteolytic activity through lung passage. This demonstrates that the virulence of the MSP-strain is not due to a reversion to MSP positivity in vivo, and confirms that MSP is not required for virulence.
Consistent with these observations, in unpublished studies, Blander and Horwitz have identified a naturally occurring (nongenetically manipulated) strain of L. pneumophila and a naturally occurring non-pneumophila species of Legionella that do not secrete MSP but are nevertheless still virulent for guinea pigs. The aerosolized doses of these strains that are 100% lethal are comparable to those of the MSP-and MSP+ strains described in this paper. lot change phenotype
In a previous study, Conlan et (13) . In this study, proteolytic activity of the MSP-mutant before and after guinea pig passage measured 0-1.9% the level in the MSP+ strain; the levels were sufficiently low so as to be below the level of accurate detection by the colorimetric assay used. Independently, Szeto and Shuman have assayed residual protease activity in the MSP-strain described here and in five other independently derived MSP-strains and found that the proteolytic activity of all strains is < 0.2% that of the MSP+ strain (15a). Although present in small amounts, other proteases may yet contribute to the pathogenicity of L. pneumophila in Legionnaires' disease.
Our 
